P1044: REAL-WORLD RUXOLITINIB TREATMENT PATTERN IN MYELOFIBROSIS PATIENTS WITH THROMBOCYTOPENIA

• J. Mei,
• Y. Wang,
• S. Kabir,
• N. Ichikawa,
• S. Iino,
• C. Lebedinsky

Affiliations

J. Mei

1 Clinical Development, Sumitomo Dainippon Pharma Oncology, Inc, Cambridge

Y. Wang

2 Computational Research, Sumitovant Biopharma, New York, United States of America

S. Kabir

1 Clinical Development, Sumitomo Dainippon Pharma Oncology, Inc, Cambridge

N. Ichikawa

3 Oncology Clinical Development Unit, Sumitomo Dainippon Pharma Co., Ltd, Osaka, Japan

S. Iino

3 Oncology Clinical Development Unit, Sumitomo Dainippon Pharma Co., Ltd, Osaka, Japan

C. Lebedinsky

1 Clinical Development, Sumitomo Dainippon Pharma Oncology, Inc, Cambridge